Aisling – DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 05/13/2026

Brand: Aisling

Product: DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL

Recall Reason: Presence of glass particles

Company: Sun Pharmaceutical Industries, Inc.

Dosage Form: Injection

Recall Issue Type: Other Recall Issue

View FDA Drug Recall Notice